Why the study?
The study sought to investigate the feasibility and safety of the 1-min sit-to-stand test as an assessment tool for functional capacity in acute decompensated heart failure.
Does the 1-minute sit-to-stand test safely assess functional capacity without worsening pulmonary edema in patients with acute decompensated heart failure?
Does the 1-minute sit-to-stand test safely assess functional capacity without worsening pulmonary edema in patients with acute decompensated heart failure?
The 1-minute sit-to-stand test is a safe and feasible tool for early functional capacity assessment in patients with acute decompensated heart failure, without exacerbating pulmonary edema.
1-min STST may be feasible post-stabilization in ADHF; leaves open validation as a functional capacity tool.
Aim This study innovatively proposed the 1-min sit-to-stand test (1-min STST) as an assessment tool for functional capacity in acute decompensated heart failure (ADHF), in which its feasibility and safety were investigated. Methods This was a prospective, single-center cohort study. The 1-min STST was performed after the first 48 h of admission when vital signs and Borg score were collected. Lung ultrasound was used to measure pulmonary edema by B-lines before and after the test. Results Seventy-five patients were enrolled in the study, of whom 40% were in functional class IV on admission. The mean age was 58.3 ± 15.7 years and 40% of the patients were male. 95% patients accomplished the test and the average number of repetitions was 18 ± 7. No adverse event was recorded during or after the 1-min STST. Blood pressure, heart rate, and degree of dyspnea were increased after the test (all p < 0.001), while oxygen saturation was slightly decreased (97.0 ± 1.6 vs. 96.3 ± 2.0%, p = 0.003). The degree of pulmonary edema (χ 2 = 8.300, p = 0.081) was not significantly changed, while there was a reduction in the absolute number of B-lines [9 (3, 16) vs. 7 (3, 13), p = 0.008]. Conclusion The application of the 1-min STST in early stage of ADHF appeared to be safe and feasible, which induce neither adverse event nor pulmonary edema. It may serve as a new tool of functional capacity assessment, as well as a reference of exercise rehabilitation.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: